Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RITONAVIR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 343 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mekapati, SB; Sivakumar, R; Gupta, SP
      Quantitative structure-activity relationship of some HIV-1 protease inhibitors: A Fujita-Ban type analysis

      JOURNAL OF ENZYME INHIBITION
    2. Veldkamp, AI; van Heeswijk, RPG; Mulder, JW; Meenhorst, PL; Schreij, G; van der Geest, S; Lange, JMA; Beijnen, JH; Hoetelmans, RMW
      Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Mole, L; Schmidgall, D; Holodniy, Y
      A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Gerber, JG; Rosenkranz, S; Segal, Y; Aberg, J; D'Amico, R; Mildvan, D; Gulick, R; Hughes, V; Flexner, C; Aweeka, F; Hsu, A; Gal, J
      Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Burger, DM; Hugen, PWH; Aarnoutse, RE; Dieleman, JP; Prins, JM; van der Poll, T; ten Veen, JH; Mulder, JW; Meenhorst, PL; Blok, WL; van der Meer, JTM; Reiss, P; Lange, JMA
      A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Aarnoutse, RE; Wissen, CPWGMVV; Underberg, WJM; Kleinnijenhuis, J; Hekster, YA; Burger, DM
      High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices

      JOURNAL OF CHROMATOGRAPHY B
    7. Dailly, E; Thomas, L; Kergueris, MF; Jolliet, P; Bourin, M
      High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavirand saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    8. Sarasa-Nacenta, M; Lopez-Pua, Y; Mallolas, J; Blanco, JL; Gatell, JM; Carne, X
      Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    9. Yamada, H; Kotaki, H; Nakamura, T; Iwamoto, A
      Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    10. Langmann, P; Schirmer, D; Vath, T; Zilly, M; Klinker, H
      High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy

      JOURNAL OF CHROMATOGRAPHY B
    11. Nieuwkerk, P; Gisolf, E; Sprangers, M; Danner, S
      Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response

      ANTIVIRAL THERAPY
    12. McMahon, D; Lederman, M; Haas, DW; Haubrich, R; Stanford, J; Cooney, E; Horton, J; Kelleher, D; Ross, L; Cutrell, A; Lee, D; Spreen, W; Mellors, JW
      Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults

      ANTIVIRAL THERAPY
    13. Kodoth, S; Bakshi, S; Scimeca, P; Black, K; Pahwa, S
      Possible linkage of amprenavir with intracranial bleeding in an HIV-infected hemophiliac

      AIDS PATIENT CARE AND STDS
    14. Blazevic, V; Jankelevich, S; Steinberg, SM; Jacobsen, F; Yarchoan, R; Shearer, GM
      Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: Analysis of cellular immune responses

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    15. James, CW; McNelis, KC; Cohen, DM; Szabo, S; Bincsik, AK
      Recurrent ingrown toenails secondary to indinavir/ritonavir combination therapy

      ANNALS OF PHARMACOTHERAPY
    16. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    17. Rayner, CR; Esch, LD; Wynn, HE; Eales, R
      Symptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimen

      ANNALS OF PHARMACOTHERAPY
    18. Duong, M; Piroth, L; Peytavin, G; Forte, F; Kohli, E; Grappin, M; Buisson, M; Chavanet, P; Portier, H
      Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response

      CLINICAL INFECTIOUS DISEASES
    19. Valdez, H; Chowdhry, TK; Asaad, R; Woolley, IJ; Davis, T; Davidson, R; Beinker, N; Gripshover, BM; Salata, RA; McComsey, G; Weissman, SB; Lederman, MM
      Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999

      CLINICAL INFECTIOUS DISEASES
    20. Youle, M
      Salvage treatment in HIV disease

      INTERNATIONAL JOURNAL OF STD & AIDS
    21. Manfredi, R; Chiodo, F
      Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

      INTERNATIONAL JOURNAL OF STD & AIDS
    22. Penzak, SR; Lawhorn, WD; Gubbins, PO
      Rapid and sensitive high-performance liquid chromatographic method for thedetermination of ritonavir in human plasma

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    23. Manfredi, R; Chiodo, F
      Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    24. Kaufmann, GR; Zaunders, J; Murray, J; Kelleher, AD; Lewin, SR; Solomon, A; Smith, D; Cooper, DA
      Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    25. Kelleher, AD; Booth, BL; Sewell, AK; Oxenius, A; Cerundolo, V; McMichael, AJ; Phillips, RE; Price, DA
      Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-Restricted cytotoxic T lymphocyte epitopes

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    26. Brechtl, JR; Breitbart, W; Galietta, M; Krivo, S; Rosenfeld, B
      The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: Impact on medical, palliative care, and quality of life outcomes

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    27. Leautez, S; Billaud, E
      The place of saquinavir in the treatment of HIV infected adult in years 2001

      PRESSE MEDICALE
    28. Reliquet, V; Robillard, N; Perre, P; Muller, JY; Raffi, F; Audrain, M
      Immune response to antiretroviral treatment combining stavudine, didanosine and nevirapine

      PRESSE MEDICALE
    29. Meynard, JL; Guiguet, M; Rachline, A; Boukli, N; Bollens, D; Gentil, C; Frottier, J; Morand-Joubert, L
      Factors predicting response to antiretroviral regimens with a protease inhibitor in HIV-infected subjects

      PRESSE MEDICALE
    30. Routy, JP; Smith, GHR; Blank, DW; Gilfix, BM
      Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor-induced hypertriglyceridemia

      JOURNAL OF CLINICAL APHERESIS
    31. Bauer, J; Spanton, S; Henry, R; Quick, J; Dziki, W; Porter, W; Morris, J
      Ritonavir: An extraordinary example of conformational polymorphism

      PHARMACEUTICAL RESEARCH
    32. Garrait, V; Molina, JM
      New strategies for antiretroviral treatment in HIV-infected patients.

      PATHOLOGIE BIOLOGIE
    33. Steiner, F; Kind, C; Aebi, LC; Wyler-Lazarevitch, CA; Cheseaux, JJ; Rudin, C; Molinari, L; Nadal, D
      Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors

      EUROPEAN JOURNAL OF PEDIATRICS
    34. Buss, N; Snell, P; Bock, J; Hsu, A; Jorga, K
      Saquinavir and ritonavir pharmacokinetics following combined ritonavir andsaquinavir (soft gelatin capsules) administration

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    35. Back, DJ; Khoo, SH; Gibbons, SE; Merry, C
      The role of therapeutic drug monitoring in treatment of HIV infection

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    36. Khaliq, Y; Gallicano, K; Tisdale, C; Carignan, G; Cooper, C; McCarthy, A
      Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    37. Koks, CHW; Crommentuyn, KML; Hoetelmans, RMW; Burger, DM; Koopmans, PP; Mathot, RAA; Mulder, JW; Meenhorst, PL; Beijnen, JH
      The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    38. Back, DJ; Khoo, SH; Gibbons, SE; Merry, C
      The role of therapeutic drug monitoring in treatment of HIV infection

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Temple, ME; Koranyi, KI; Nahata, MC
      The safety and antiviral effect of protease inhibitors in children

      PHARMACOTHERAPY
    40. Reed, JB; Briggs, JW; McDonald, JC; Freeman, WR; Morse, LS
      Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis - Long-term results in a small case series

      RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
    41. Sadler, BM; Piliero, PJ; Preston, SL; Lloyd, PP; Lou, Y; Stein, DS
      Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers

      AIDS
    42. Noor, MA; Lo, JC; Mulligan, K; Schwarz, JM; Halvorsen, RA; Schambelan, M; Grunfeld, C
      Metabolic effects of indinavir in healthy HIV-seronegative men

      AIDS
    43. Kemper, CA; Witt, MD; Keiser, PH; Dube, MP; Forthal, DN; Leibowitz, M; Smith, DS; Rigby, A; Hellmann, NS; Lie, YS; Leedom, J; Richman, D; McCutchan, JA; Haubrich, R
      Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors

      AIDS
    44. van der Sandt, ICJ; Vos, CMP; Nabulsi, L; Blom-Roosemalen, MCM; Voorwinden, HH; de Boer, AG; Breimer, DD
      Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier

      AIDS
    45. Mocroft, A; Phillips, AN; Miller, V; Gatell, J; van Lunzen, J; Parkin, JM; Weber, R; Roge, B; Lazzarin, A; Lundgren, JD
      The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

      AIDS
    46. Nieuwkerk, PT; Gisolf, EH; Reijers, MHE; Lange, JMA; Danner, SA; Sprangers, MAG
      Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection

      AIDS
    47. Murphy, RL; Brun, S; Hicks, C; Eron, JT; Gulick, R; King, M; White, AC; Benson, C; Thompson, M; Kessler, HA; Hammer, S; Bertz, R; Hsu, A; Japour, A; Sun, E
      ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

      AIDS
    48. Kumar, GN; Surapaneni, S
      Role of drug metabolism in drug discovery and development

      MEDICINAL RESEARCH REVIEWS
    49. McCloskey, TW; Kohn, N; Lesser, M; Bakshi, S; Pahwa, S
      Immunophenotypic analysis of HIV-infected children: Alterations within thefirst year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets

      CYTOMETRY
    50. Manfredi, R; Chiodo, F
      Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: Frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

      JOURNAL OF INFECTION
    51. Leibenguth, P; Le Guellec, C; Besnier, JM; Bastides, F; Mace, M; Gaudet, ML; Autret-Leca, E; Paintaud, G
      Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection

      THERAPEUTIC DRUG MONITORING
    52. Pellegrin, I; Breilh, D; Birac, V; Deneyrolles, M; Mercie, P; Trylesinski, A; Neau, D; Saux, MC; Fleury, HJA; Pellegrin, JL
      Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens

      THERAPEUTIC DRUG MONITORING
    53. Bouley, M; Briere, C; Padoin, C; Petitjean, O; Tod, M
      Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography

      THERAPEUTIC DRUG MONITORING
    54. Scott, T; Garris, C; Rogers, M; Graham, N; Garrett, L; Pedneault, L
      Safety profile and tolerability of amprenavir in patients enrolled in an early access program

      CLINICAL THERAPEUTICS
    55. Gill, J; Feinberg, J
      Saquinavir soft gelatin capsule - A comparative safety review

      DRUG SAFETY
    56. Servais, J; Lambert, C; Fontaine, E; Plesseria, JM; Robert, I; Arendt, V; Staub, T; Schneider, F; Hemmer, R; Burtonboy, G; Schmit, JC
      Comparison of DNA sequencing and a line probe assay for detection of humanimmunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy

      JOURNAL OF CLINICAL MICROBIOLOGY
    57. Chiba, M; Jin, LX; Neway, W; Vacca, JP; Tata, JR; Chapman, K; Lin, JH
      P450 interaction with HIV protease inhibitors: Relationship between metabolic stability, inhibitory potency, and p450 binding spectra

      DRUG METABOLISM AND DISPOSITION
    58. Lindsten, K; Uhlikova, T; Konvalinka, J; Masucci, MG; Dantuma, NP
      Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    59. Mittler, J; Essunger, P; Yuen, GJ; Clendeninn, N; Markowitz, M; Perelson, AS
      Short-term measures of relative efficacy predict longer-term reductions inhuman immunodeficiency virus type 1 RNA levels following nelfinavir monotherapy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    60. Zhang, KYE; Wu, E; Patick, AK; Kerr, B; Zorbas, M; Lankford, A; Kobayashi, T; Maeda, Y; Shetty, B; Webber, S
      Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: Structural identification, levels in plasma, andantiviral activities

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    61. Servais, J; Lambert, C; Fontaine, E; Plesseria, JM; Robert, I; Arendt, V; Staub, T; Schneider, F; Hemmer, R; Burtonboy, G; Schmit, JC
      Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    62. Hachiya, A; Aizawa-Matsuoka, S; Tanaka, M; Takahashi, Y; Ida, S; Gatanaga, H; Hirabayashi, Y; Kojima, A; Tatsumi, M; Oka, S
      Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    63. Polk, RE; Brophy, DF; Israel, DS; Patron, R; Sadler, BM; Chittick, GE; Symonds, WT; Lou, Y; Kristoff, D; Stein, DS
      Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    64. Sadler, BM; Gillotin, C; Lou, Y; Eron, JJ; Lang, W; Haubrich, R; Stein, DS
      Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    65. van Praag, RME; Repping, S; de Vries, JWA; Lange, JMA; Hoetelmans, RMW; Prins, JM
      Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    66. Sadler, BM; Gillotin, C; Lou, Y; Stein, DS
      Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    67. Gillenwater, DR; McDaniel, JS
      Rational psychopharmacology for patients with HIV infection and AIDS

      PSYCHIATRIC ANNALS
    68. Armstrong, SC; Cozza, KL
      Consultation-liaison psychiatry drug-drug interactions update

      PSYCHOSOMATICS
    69. Buchacz, K; Cervia, JS; Lindsey, JC; Hughes, MD; Seage, GR; Dankner, WM; Oleske, JM; Moye, J
      Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children

      PEDIATRICS
    70. Miller, TL; Mawn, BE; Orav, EJ; Wilk, D
      The effect of protease inhibitor therapy on growth and body composition inhuman immunodeficiency virus type 1-infected children

      PEDIATRICS
    71. Gortmaker, SL; Hughes, M; Cervia, J; Brady, M; Johnson, GM; Seage, GR; Song, LY; Dankner, WM; Oleske, JM
      Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1

      NEW ENGLAND JOURNAL OF MEDICINE
    72. Kempf, DJ; Isaacson, JD; King, MS; Brun, SC; Xu, Y; Real, K; Bernstein, BM; Japour, AJ; Sun, E; Rode, RA
      Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients

      JOURNAL OF VIROLOGY
    73. Law, D; Krill, SL; Schmitt, EA; Fort, JJ; Qiu, YH; Wang, WL; Porter, WR
      Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions

      JOURNAL OF PHARMACEUTICAL SCIENCES
    74. Perloff, MD; von Moltke, LL; Marchand, JE; Greenblatt, DJ
      Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line

      JOURNAL OF PHARMACEUTICAL SCIENCES
    75. Gulick, RM; Smeaton, LM; D'Aquila, RT; Eron, JJ; Currier, JS; Gerber, JG; Acosta, E; Sommadossi, JP; Tung, R; Snyder, S; Kuritzkes, DR; Murphy, RL
      Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir- experienced subjects: AIDS Clinical Trials Group protocol 373

      JOURNAL OF INFECTIOUS DISEASES
    76. Angel, JB; Parato, KG; Kumar, A; Kravcik, S; Badley, AD; Fex, C; Ashby, D; Sun, E; Cameron, DW
      Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression

      JOURNAL OF INFECTIOUS DISEASES
    77. Perez, EE; Rose, SL; Peyser, B; Lamers, SL; Burkhardt, B; Dunn, BM; Hutson, AD; Sleasman, JW; Goodenow, MM
      Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients

      JOURNAL OF INFECTIOUS DISEASES
    78. Blankson, JN; Gallant, JE; Siliciano, RF
      Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution

      JOURNAL OF INFECTIOUS DISEASES
    79. Faux, J; Venisse, N; Olivier, JC; Bouquet, S
      Rapid high-performance liquid chromatography determination of lopinavir, anovel HIV-1 protease inhibitor, in human plasma

      CHROMATOGRAPHIA
    80. Phenix, BN; Lum, JJ; Nie, Z; Sanchez-Dardon, J; Badley, AD
      Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

      BLOOD
    81. Markgren, PO; Lindgren, MT; Gertow, K; Karlsson, R; Hamalainen, M; Danielson, UH
      Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology

      ANALYTICAL BIOCHEMISTRY
    82. Domingo, P; Torres, OH; Ris, J; Vazquez, G
      Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

      AMERICAN JOURNAL OF MEDICINE
    83. Gutleben, W; Tuan, ND; Stoiber, H; Dierich, MP; Sarcletti, M; Zemann, A
      Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy

      JOURNAL OF CHROMATOGRAPHY A
    84. Gunawan, S; Griswold, MP; Kahn, DG
      Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy

      JOURNAL OF CHROMATOGRAPHY A
    85. Simon, VA; Thiam, MD; Lipford, LC
      Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY A
    86. Picchio, GR; Valdez, H; Sabbe, R; Landay, AL; Kuritzkes, DR; Lederman, MM; Mosier, DE
      Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    87. Mallolas, J; Blanco, JL; Sarasa, M; Giner, V; Martinez, E; Garcia-Viejo, MA; Arnaiz, JA; Cruceta, A; Soy, D; Tuset, M; Soriano, A; Codina, C; Pumarola, T; Carne, X; Gatell, JM
      Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    88. Hugen, PWH; Burger, DM; ter Hofstede, HJM; Koopmans, PP; Stek, M; Hekster, YA; Reiss, P; Lange, JMA
      Dose-finding study of a once-daily indinavir/ritonavir regimen

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    89. Weinberg, A; Wohl, DA; Brown, DG; Pott, GB; Zhang, L; Ray, MG; van der Horst, C
      Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    90. Moss, RB; Webb, E; Giermakowska, WK; Jensen, FC; Savary, JR; Wallace, MR; Carlo, DJ
      HIV-1-specific CD4 helper function in persons with chronic HIV-1 infectionon antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    91. Bini, T; Testa, L; Chiesa, E; Adorni, F; Abeli, C; Castelnuovo, B; Melzi, S; Sollima, S; Bongiovanni, M; Monforte, AD
      Outcome of a second-line protease inhibitor-containing regimen in patientsfailing or intolerant of a first highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    92. Greenblatt, DJ; von Moltke, LL; Harmatz, JS; Durol, ALB; Daily, JP; Graf, JA; Mertzanis, P; Hoffman, JL; Shader, RI
      Differential impairment of triazolam and zolpidem clearance by ritonavir

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    93. Piroth, L; Grappin, M; Buisson, M; Duong, M; Portier, H; Chavanet, P
      Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    94. Bonfanti, P; Valsecchi, L; Parazzini, F; Carradori, S; Pusterla, L; Fortuna, P; Timillero, L; Alessi, F; Ghiselli, G; Gabbuti, A; Di Cintio, E; Martinelli, C; Faggion, I; Landonio, S; Quirino, T
      Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    95. Thiebaut, R; Dabis, F; Malvy, F; Jacqmin-Gadda, H; Mercie, P; Valentin, VD
      Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    96. Proust, V; Toth, K; Hulin, A; Taburet, AM; Gimenez, F; Singlas, E
      Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

      JOURNAL OF CHROMATOGRAPHY B
    97. Sparidans, RW; Hoetelmans, RMW; Beijnen, JH
      Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

      JOURNAL OF CHROMATOGRAPHY B
    98. Marzolini, C; Telenti, A; Buclin, T; Biollaz, J; Decosterd, LA
      Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

      JOURNAL OF CHROMATOGRAPHY B
    99. Re, MC; Ramazzotti, E; Manfredi, R; Furlini, G; Vignoli, M; Maldini, C; Borderi, M; La Placa, M
      Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART

      JOURNAL OF CLINICAL VIROLOGY
    100. Kaufmann, GR; Cooper, DA
      Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options

      CURRENT OPINION IN MICROBIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 07:30:49